Partnership for Breast Care

Home/About Us
Q&As
Other Resources
How You Can Help
News/Articles
Print Documents
Contact Us
Search the Site
Breast Problems Providers Support Services Clinical Research Breast Health
Current Breast Care Trials at HH

Adjuvant Trials are those trials that combine treatment with surgery.

NSABP B-35:   A Clinical Trial Comparing Anastrozole with Tamoxifen in postmenopausal patients with Ductal Carcinoma in-Situ (DCIS) undergoing lumpectomy with radiation therapy.

NSABP B-36:  A clinical trial of adjuvant therapy comparing six cycles of 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) to four cycles of Adriamycin and Cyclophosphamide (AC), with or without Celecoxib, in patients with node-negative breast cancer.

NSABP B-38:  A Phase III, adjuvant trial comparing three chemotherapy regimens in women with node-positive breast cancer: Docetaxel/Doxorubicin/Cyclophosphamide (TAC); dose-dense (DD) Doxorubicin/Cyclophosphamide followed by DD Paclitaxel (DD ACP); DD AC followed by DD Paclitaxel plus Gemcitabine (DD AC→PG).

NSABP B-39:  Trial initiation of NSABP B-39/RTOG 0413:  A randomized phase III study of conventional whole breast irratiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II, breast cancer.

CALGB 40101:  Cyclophosphamide and Doxorubicin (CA) (4 Cycles vs. 6 Cycles) versus Pacitaxel (12 weeks vs 18 weeks) as adjuvant therapy for women with node negative breast cancer: A 2 x 2 factorial phase III randomized study.

IBCSG 24-02 Soft:  Suppression of Ovarian Function Trial: A Phase III trial evaluating the role of ovarian function suppression and the role of Exemestane adjuvant therapies for premenopausal women with endocrine responsive breast cancer.

NCIC MA.27:  A randomized phase III trial of Exemestane versus Anastrozole in postmenpausal women with receptor positive primary breast cancer.

For more information about adjuvant trials at Hartford Hospital, please contact:

Camille A. Servodidio, RN, MPH, CRNO, OCN, CCRP - Program Coordinator, Cancer Clinical Research Office, Cancer Program- Hartford Hospital
Phone:(860) 545-5363
Email: cservod@harthosp.org


Prevention Trials

Clinical Trials
for Treatments
Combined with
Surgery (Adjuvant)

Metastatic Disease
Clinical Trials


Screening Trials

Quality of Life